Home › Funds › SPHERA FUNDS MANAGEMENT LTD. › CBIO
SPHERA FUNDS MANAGEMENT LTD. position in CBIO
CRESCENT BIOPHARMA INC. · Health Care
SPHERA FUNDS MANAGEMENT LTD. reported holding 279,718 shares of CBIO (CRESCENT BIOPHARMA INC.) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 0.63% of its reported portfolio and ranking #48 among its reported holdings. SPHERA FUNDS MANAGEMENT LTD. first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How SPHERA FUNDS MANAGEMENT LTD.'s CBIO position evolved
SPHERA FUNDS MANAGEMENT LTD. first disclosed a stake in CBIO in Q3 2026 at 279,718 shares (US$4.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 279.72K | $4.08M | New |
About CBIO and 13F data
CBIO (CRESCENT BIOPHARMA INC.) is a Health Care company. 66 other funds we track also report a position in CBIO — the largest reported positions include Fairmount Funds Management LLC (US$52.5M), BVF INC/IL (US$45.1M), Vestal Point Capital, LP (US$43.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CBIO
- Fairmount Funds Management LLC 3.60M sh · $52.54M · Q3 2026
- BVF INC/IL 3.09M sh · $45.14M · Q3 2026
- Vestal Point Capital, LP 3.00M sh · $43.77M · Q3 2026
- Venrock Adviser, LLC 2.13M sh · $31.13M · Q3 2026
- FCPM III SERVICES B.V. 2.02M sh · $29.51M · Q3 2026
- Opaleye Management Inc. 1.32M sh · $23.75M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.16M sh · $16.92M · Q3 2026
- Logos Global Management LP 850.00K sh · $12.40M · Q3 2026
- NEXTBio Capital Management LP 372.86K sh · $5.44M · Q3 2026
- Remedium Capital Partners, LLC 361.25K sh · $5.27M · Q3 2026
- Squadron Capital Management LLC 350.00K sh · $5.11M · Q3 2026
- Boxer Capital Management, LLC 226.84K sh · $3.31M · Q3 2026
More on SPHERA FUNDS MANAGEMENT LTD.
FAQ
How long has SPHERA FUNDS MANAGEMENT LTD. held CBIO?
SPHERA FUNDS MANAGEMENT LTD. has disclosed CBIO holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is SPHERA FUNDS MANAGEMENT LTD.'s current position in CBIO?
As of Q3 2026, SPHERA FUNDS MANAGEMENT LTD. holds 279.72K shares of CBIO (CRESCENT BIOPHARMA INC.), valued at $4.08M, representing 0.63% of its reported portfolio and ranking #48.
Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling CBIO?
In the latest 13F filing (Q3 2026), SPHERA FUNDS MANAGEMENT LTD. newly opened its position in CBIO.
Which other funds hold CBIO?
Other major institutional holders of CBIO include Fairmount Funds Management LLC, BVF INC/IL, Vestal Point Capital, LP, among 66 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.